nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—embryo—testicular cancer	0.0541	0.47	CbGeAlD
Pentosan Polysulfate—FGF1—embryo—testicular cancer	0.0143	0.124	CbGeAlD
Pentosan Polysulfate—FGF2—female gonad—testicular cancer	0.0106	0.0921	CbGeAlD
Pentosan Polysulfate—FGF2—testis—testicular cancer	0.00941	0.0817	CbGeAlD
Pentosan Polysulfate—FGF1—female gonad—testicular cancer	0.00789	0.0685	CbGeAlD
Pentosan Polysulfate—FGF1—testis—testicular cancer	0.007	0.0607	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—testicular cancer	0.00682	0.0592	CbGeAlD
Pentosan Polysulfate—FGF1—lymph node—testicular cancer	0.00507	0.044	CbGeAlD
Pentosan Polysulfate—FGF2—GAB1 signalosome—KITLG—testicular cancer	0.0017	0.00296	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by SCF-KIT—FGFR3—testicular cancer	0.00168	0.00294	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.00168	0.00293	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—BCL10—testicular cancer	0.00168	0.00293	CbGpPWpGaD
Pentosan Polysulfate—FGF4—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.00167	0.00292	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—KITLG—testicular cancer	0.00166	0.0029	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by Insulin receptor—STK11—testicular cancer	0.00165	0.00289	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.00161	0.00281	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.00161	0.00281	CbGpPWpGaD
Pentosan Polysulfate—FGF1—IRS-mediated signalling—FGFR3—testicular cancer	0.0016	0.0028	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Constitutive PI3K/AKT Signaling in Cancer—FGFR3—testicular cancer	0.00158	0.00277	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by ERBB4—FGFR3—testicular cancer	0.00158	0.00277	CbGpPWpGaD
Pentosan Polysulfate—FGF1—IRS-related events—FGFR3—testicular cancer	0.00156	0.00272	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by SCF-KIT—KIT—testicular cancer	0.00154	0.0027	CbGpPWpGaD
Pentosan Polysulfate—FGF1—IRS-related events triggered by IGF1R—FGFR3—testicular cancer	0.00154	0.00269	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.00153	0.00267	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Downstream signal transduction—FGFR3—testicular cancer	0.00151	0.00264	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by FGFR—FGFR3—testicular cancer	0.0015	0.00263	CbGpPWpGaD
Pentosan Polysulfate—FGF1—IGF1R signaling cascade—FGFR3—testicular cancer	0.0015	0.00262	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Insulin receptor signalling cascade—FGFR3—testicular cancer	0.0015	0.00262	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by ERBB2—FGFR3—testicular cancer	0.0015	0.00262	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 signaling—FGFR3—testicular cancer	0.00149	0.0026	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Downstream signaling of activated FGFR—KIT—testicular cancer	0.00148	0.00258	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.00147	0.00257	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IRS-mediated signalling—FGFR3—testicular cancer	0.00146	0.00255	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Constitutive PI3K/AKT Signaling in Cancer—KIT—testicular cancer	0.00145	0.00254	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by ERBB4—KIT—testicular cancer	0.00145	0.00254	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Constitutive PI3K/AKT Signaling in Cancer—FGFR3—testicular cancer	0.00145	0.00253	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—KITLG—testicular cancer	0.00144	0.00251	CbGpPWpGaD
Pentosan Polysulfate—FGF1—PI-3K cascade—FGFR3—testicular cancer	0.00143	0.00249	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IRS-related events—FGFR3—testicular cancer	0.00142	0.00248	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IRS-related events triggered by IGF1R—FGFR3—testicular cancer	0.00141	0.00246	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 interactions—FGFR3—testicular cancer	0.0014	0.00245	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by FGFR in disease—FGFR3—testicular cancer	0.0014	0.00245	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.0014	0.00245	CbGpPWpGaD
Pentosan Polysulfate—FGF1—PI3K/AKT activation—FGFR3—testicular cancer	0.00139	0.00244	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR—FGFR3—testicular cancer	0.00139	0.00243	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Downstream signal transduction—KIT—testicular cancer	0.00139	0.00243	CbGpPWpGaD
Pentosan Polysulfate—FGF1—GAB1 signalosome—FGFR3—testicular cancer	0.00138	0.00242	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by FGFR—KIT—testicular cancer	0.00138	0.00241	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.00138	0.00241	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by ERBB2—KIT—testicular cancer	0.00137	0.0024	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—KITLG—testicular cancer	0.00137	0.0024	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by PDGF—FGFR3—testicular cancer	0.00137	0.0024	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IGF1R signaling cascade—FGFR3—testicular cancer	0.00137	0.00239	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Insulin receptor signalling cascade—FGFR3—testicular cancer	0.00137	0.00239	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 signaling—KIT—testicular cancer	0.00137	0.00239	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—KITLG—testicular cancer	0.00135	0.00236	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—FGFR3—testicular cancer	0.00135	0.00236	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.00135	0.00236	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Constitutive PI3K/AKT Signaling in Cancer—KIT—testicular cancer	0.00133	0.00232	CbGpPWpGaD
Pentosan Polysulfate—FGF1—PI-3K cascade—KIT—testicular cancer	0.00131	0.00229	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—KITLG—testicular cancer	0.00131	0.00229	CbGpPWpGaD
Pentosan Polysulfate—FGF2—PI-3K cascade—FGFR3—testicular cancer	0.0013	0.00227	CbGpPWpGaD
Pentosan Polysulfate—FGF4—B Cell Activation—FGFR3—testicular cancer	0.0013	0.00227	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—KITLG—testicular cancer	0.00129	0.00226	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by FGFR in disease—KIT—testicular cancer	0.00129	0.00225	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.00129	0.00225	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 interactions—KIT—testicular cancer	0.00129	0.00225	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—KITLG—testicular cancer	0.00128	0.00225	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—KITLG—testicular cancer	0.00128	0.00224	CbGpPWpGaD
Pentosan Polysulfate—FGF1—PI3K/AKT activation—KIT—testicular cancer	0.00128	0.00224	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—KITLG—testicular cancer	0.00128	0.00223	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR—KIT—testicular cancer	0.00128	0.00223	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—KITLG—testicular cancer	0.00127	0.00222	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Neural Crest Differentiation—FGFR3—testicular cancer	0.00127	0.00222	CbGpPWpGaD
Pentosan Polysulfate—FGF2—PI3K/AKT activation—FGFR3—testicular cancer	0.00127	0.00222	CbGpPWpGaD
Pentosan Polysulfate—FGF1—GAB1 signalosome—KIT—testicular cancer	0.00127	0.00222	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR in Cancer—KIT—testicular cancer	0.00126	0.00221	CbGpPWpGaD
Pentosan Polysulfate—FGF2—GAB1 signalosome—FGFR3—testicular cancer	0.00126	0.0022	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by PDGF—KIT—testicular cancer	0.00126	0.0022	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—KITLG—testicular cancer	0.00125	0.00219	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—KITLG—testicular cancer	0.00125	0.00219	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by Insulin receptor—FGFR3—testicular cancer	0.00125	0.00218	CbGpPWpGaD
Pentosan Polysulfate—FGF4—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.00124	0.00217	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—testicular cancer	0.00124	0.00217	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—KITLG—testicular cancer	0.00123	0.00215	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—FGFR3—testicular cancer	0.00123	0.00215	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.00122	0.00213	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—BCL10—testicular cancer	0.00122	0.00212	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.0012	0.00209	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—KITLG—testicular cancer	0.0012	0.00209	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—KITLG—testicular cancer	0.0012	0.00209	CbGpPWpGaD
Pentosan Polysulfate—FGF2—PI-3K cascade—KIT—testicular cancer	0.0012	0.00209	CbGpPWpGaD
Pentosan Polysulfate—FGF4—B Cell Activation—KIT—testicular cancer	0.00119	0.00208	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—KITLG—testicular cancer	0.00119	0.00207	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—KITLG—testicular cancer	0.00118	0.00206	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.00118	0.00205	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—KITLG—testicular cancer	0.00117	0.00205	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—KITLG—testicular cancer	0.00117	0.00205	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—BCL10—testicular cancer	0.00117	0.00204	CbGpPWpGaD
Pentosan Polysulfate—FGF2—PI3K/AKT activation—KIT—testicular cancer	0.00117	0.00204	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—KITLG—testicular cancer	0.00117	0.00204	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—KITLG—testicular cancer	0.00116	0.00203	CbGpPWpGaD
Pentosan Polysulfate—FGF2—GAB1 signalosome—KIT—testicular cancer	0.00116	0.00202	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—KITLG—testicular cancer	0.00114	0.002	CbGpPWpGaD
Pentosan Polysulfate—FGF4—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.00114	0.00199	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by Insulin receptor—FGFR3—testicular cancer	0.00114	0.00199	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—testicular cancer	0.00113	0.00198	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.00111	0.00194	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—KITLG—testicular cancer	0.00111	0.00194	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.00109	0.00191	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—KITLG—testicular cancer	0.00109	0.00191	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—KITLG—testicular cancer	0.00109	0.00191	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—KITLG—testicular cancer	0.00108	0.00189	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.00107	0.00187	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—KITLG—testicular cancer	0.00107	0.00187	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—FGFR3—testicular cancer	0.00107	0.00186	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.00106	0.00185	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.00102	0.00178	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.00102	0.00178	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—KITLG—testicular cancer	0.00101	0.00177	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—FGFR3—testicular cancer	0.001	0.00176	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—KIT—testicular cancer	0.00098	0.00171	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—FGFR3—testicular cancer	0.000973	0.0017	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000967	0.00169	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—FGFR3—testicular cancer	0.00096	0.00168	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—FGFR3—testicular cancer	0.000955	0.00167	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—FGFR3—testicular cancer	0.000955	0.00167	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—FGFR3—testicular cancer	0.00095	0.00166	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—FGFR3—testicular cancer	0.000946	0.00165	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000937	0.00164	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—INSL3—testicular cancer	0.000937	0.00164	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.000932	0.00163	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000931	0.00163	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	0.000931	0.00163	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—KIT—testicular cancer	0.000923	0.00161	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—FGFR3—testicular cancer	0.000916	0.0016	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—KIT—testicular cancer	0.000893	0.00156	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—FGFR3—testicular cancer	0.00089	0.00155	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—FGFR3—testicular cancer	0.00089	0.00155	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.00089	0.00155	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—FGFR3—testicular cancer	0.000882	0.00154	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—KIT—testicular cancer	0.000881	0.00154	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—KIT—testicular cancer	0.000877	0.00153	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—KIT—testicular cancer	0.000877	0.00153	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—FGFR3—testicular cancer	0.000875	0.00153	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000874	0.00153	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—KIT—testicular cancer	0.000872	0.00152	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—FGFR3—testicular cancer	0.000871	0.00152	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—FGFR3—testicular cancer	0.00087	0.00152	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—KIT—testicular cancer	0.000868	0.00152	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—FGFR3—testicular cancer	0.000866	0.00151	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—FGFR3—testicular cancer	0.000862	0.00151	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.000856	0.0015	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000855	0.00149	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—testicular cancer	0.00085	0.00149	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—KIT—testicular cancer	0.000841	0.00147	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—FGFR3—testicular cancer	0.000823	0.00144	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—KIT—testicular cancer	0.000817	0.00143	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—KIT—testicular cancer	0.000817	0.00143	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000817	0.00143	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—KITLG—testicular cancer	0.000815	0.00142	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—FGFR3—testicular cancer	0.000811	0.00142	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	0.000811	0.00142	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—FGFR3—testicular cancer	0.000811	0.00142	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—KIT—testicular cancer	0.000809	0.00141	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—FGFR3—testicular cancer	0.000804	0.0014	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—KIT—testicular cancer	0.000803	0.0014	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000802	0.0014	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—KIT—testicular cancer	0.000799	0.0014	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—KIT—testicular cancer	0.000799	0.0014	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—FGFR3—testicular cancer	0.000797	0.00139	CbGpPWpGaD
Pentosan Polysulfate—Oedema—Ifosfamide—testicular cancer	0.000796	0.00255	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—KIT—testicular cancer	0.000796	0.00139	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—FGFR3—testicular cancer	0.000793	0.00139	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000792	0.00253	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 signaling—KIT—testicular cancer	0.000792	0.00138	CbGpPWpGaD
Pentosan Polysulfate—Infection—Ifosfamide—testicular cancer	0.000791	0.00253	CcSEcCtD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000788	0.00138	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Etoposide—testicular cancer	0.000782	0.0025	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Cisplatin—testicular cancer	0.000781	0.0025	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—KIT—testicular cancer	0.00078	0.00136	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Ifosfamide—testicular cancer	0.00078	0.00249	CcSEcCtD
Pentosan Polysulfate—Anaemia—Cisplatin—testicular cancer	0.000778	0.00249	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—BCL10—testicular cancer	0.000771	0.00135	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Ifosfamide—testicular cancer	0.00077	0.00246	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Bleomycin—testicular cancer	0.000768	0.00246	CcSEcCtD
Pentosan Polysulfate—Vomiting—Chlorambucil—testicular cancer	0.000766	0.00245	CcSEcCtD
Pentosan Polysulfate—Anorexia—Ifosfamide—testicular cancer	0.000759	0.00243	CcSEcCtD
Pentosan Polysulfate—Malaise—Cisplatin—testicular cancer	0.000759	0.00243	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Doxorubicin—testicular cancer	0.000756	0.00242	CcSEcCtD
Pentosan Polysulfate—FGF1—B Cell Activation—KIT—testicular cancer	0.000756	0.00132	CbGpPWpGaD
Pentosan Polysulfate—Decreased appetite—Dactinomycin—testicular cancer	0.000755	0.00242	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vinblastine—testicular cancer	0.000755	0.00241	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Cisplatin—testicular cancer	0.000753	0.00241	CcSEcCtD
Pentosan Polysulfate—FGF2—B Cell Activation—FGFR3—testicular cancer	0.000751	0.00131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	0.000745	0.0013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—KIT—testicular cancer	0.000745	0.0013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—KIT—testicular cancer	0.000745	0.0013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—KITLG—testicular cancer	0.000744	0.0013	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—BCL10—testicular cancer	0.000741	0.00129	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Bleomycin—testicular cancer	0.00074	0.00237	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by EGFR—KIT—testicular cancer	0.000738	0.00129	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—KITLG—testicular cancer	0.000733	0.00128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—KIT—testicular cancer	0.000732	0.00128	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Vinblastine—testicular cancer	0.00073	0.00233	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by PDGF—KIT—testicular cancer	0.000728	0.00127	CbGpPWpGaD
Pentosan Polysulfate—Mood swings—Methotrexate—testicular cancer	0.000726	0.00232	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000726	0.00232	CcSEcCtD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.000723	0.00126	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	0.000718	0.00126	CbGpPWpGaD
Pentosan Polysulfate—Myalgia—Cisplatin—testicular cancer	0.000716	0.00229	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Dactinomycin—testicular cancer	0.000716	0.00229	CcSEcCtD
Pentosan Polysulfate—Nausea—Chlorambucil—testicular cancer	0.000715	0.00229	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Ifosfamide—testicular cancer	0.000715	0.00229	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Etoposide—testicular cancer	0.000715	0.00229	CcSEcCtD
Pentosan Polysulfate—Anaemia—Etoposide—testicular cancer	0.000712	0.00228	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000711	0.00227	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Ifosfamide—testicular cancer	0.00071	0.00227	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Methotrexate—testicular cancer	0.000708	0.00226	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—BCL10—testicular cancer	0.000708	0.00124	CbGpPWpGaD
Pentosan Polysulfate—Discomfort—Cisplatin—testicular cancer	0.000708	0.00226	CcSEcCtD
Pentosan Polysulfate—Affect lability—Epirubicin—testicular cancer	0.000706	0.00226	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—KITLG—testicular cancer	0.000704	0.00123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—BCL10—testicular cancer	0.000703	0.00123	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Vinblastine—testicular cancer	0.000702	0.00224	CcSEcCtD
Pentosan Polysulfate—Malaise—Etoposide—testicular cancer	0.000695	0.00222	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Ifosfamide—testicular cancer	0.000692	0.00221	CcSEcCtD
Pentosan Polysulfate—Headache—Vinblastine—testicular cancer	0.000691	0.00221	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Etoposide—testicular cancer	0.00069	0.00221	CcSEcCtD
Pentosan Polysulfate—FGF2—B Cell Activation—KIT—testicular cancer	0.000689	0.0012	CbGpPWpGaD
Pentosan Polysulfate—Abdominal pain—Dactinomycin—testicular cancer	0.000687	0.0022	CcSEcCtD
Pentosan Polysulfate—Oedema—Cisplatin—testicular cancer	0.000687	0.0022	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Bleomycin—testicular cancer	0.000687	0.0022	CcSEcCtD
Pentosan Polysulfate—Infection—Cisplatin—testicular cancer	0.000682	0.00218	CcSEcCtD
Pentosan Polysulfate—Constipation—Ifosfamide—testicular cancer	0.000681	0.00218	CcSEcCtD
Pentosan Polysulfate—Mood swings—Epirubicin—testicular cancer	0.00068	0.00217	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—BCL10—testicular cancer	0.000675	0.00118	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Cisplatin—testicular cancer	0.000672	0.00215	CcSEcCtD
Pentosan Polysulfate—Dehydration—Epirubicin—testicular cancer	0.000667	0.00213	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Cisplatin—testicular cancer	0.000664	0.00212	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Epirubicin—testicular cancer	0.000662	0.00212	CcSEcCtD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	0.00066	0.00115	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Bleomycin—testicular cancer	0.000659	0.00211	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Ifosfamide—testicular cancer	0.000656	0.0021	CcSEcCtD
Pentosan Polysulfate—Nausea—Vinblastine—testicular cancer	0.000655	0.0021	CcSEcCtD
Pentosan Polysulfate—Anorexia—Cisplatin—testicular cancer	0.000654	0.00209	CcSEcCtD
Pentosan Polysulfate—Affect lability—Doxorubicin—testicular cancer	0.000653	0.00209	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000651	0.00208	CcSEcCtD
Pentosan Polysulfate—Discomfort—Etoposide—testicular cancer	0.000648	0.00207	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Dactinomycin—testicular cancer	0.00064	0.00205	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Methotrexate—testicular cancer	0.000635	0.00203	CcSEcCtD
Pentosan Polysulfate—Gastritis—Epirubicin—testicular cancer	0.000635	0.00203	CcSEcCtD
Pentosan Polysulfate—Urticaria—Ifosfamide—testicular cancer	0.000633	0.00202	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Ifosfamide—testicular cancer	0.00063	0.00201	CcSEcCtD
Pentosan Polysulfate—Mood swings—Doxorubicin—testicular cancer	0.000629	0.00201	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000626	0.002	CcSEcCtD
Pentosan Polysulfate—Infection—Etoposide—testicular cancer	0.000625	0.002	CcSEcCtD
Pentosan Polysulfate—Dehydration—Doxorubicin—testicular cancer	0.000617	0.00197	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Cisplatin—testicular cancer	0.000617	0.00197	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Etoposide—testicular cancer	0.000616	0.00197	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Doxorubicin—testicular cancer	0.000613	0.00196	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Cisplatin—testicular cancer	0.000612	0.00196	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Etoposide—testicular cancer	0.000608	0.00195	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by NGF—FGFR3—testicular cancer	0.000606	0.00106	CbGpPWpGaD
Pentosan Polysulfate—Photosensitivity reaction—Methotrexate—testicular cancer	0.000605	0.00193	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Epirubicin—testicular cancer	0.000604	0.00193	CcSEcCtD
Pentosan Polysulfate—Anorexia—Etoposide—testicular cancer	0.0006	0.00192	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Cisplatin—testicular cancer	0.000597	0.00191	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling Pathways—INSL3—testicular cancer	0.000595	0.00104	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Dactinomycin—testicular cancer	0.000595	0.0019	CcSEcCtD
Pentosan Polysulfate—Vomiting—Bleomycin—testicular cancer	0.000592	0.0019	CcSEcCtD
Pentosan Polysulfate—Depression—Methotrexate—testicular cancer	0.000589	0.00188	CcSEcCtD
Pentosan Polysulfate—Rash—Bleomycin—testicular cancer	0.000588	0.00188	CcSEcCtD
Pentosan Polysulfate—Gastritis—Doxorubicin—testicular cancer	0.000587	0.00188	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Bleomycin—testicular cancer	0.000587	0.00188	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Ifosfamide—testicular cancer	0.000587	0.00188	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Methotrexate—testicular cancer	0.000576	0.00184	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Methotrexate—testicular cancer	0.000574	0.00184	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Epirubicin—testicular cancer	0.000573	0.00183	CcSEcCtD
Pentosan Polysulfate—Sweating—Methotrexate—testicular cancer	0.000566	0.00181	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Epirubicin—testicular cancer	0.000566	0.00181	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Cisplatin—testicular cancer	0.000566	0.00181	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Etoposide—testicular cancer	0.000565	0.00181	CcSEcCtD
Pentosan Polysulfate—Weight increased—Epirubicin—testicular cancer	0.000564	0.0018	CcSEcCtD
Pentosan Polysulfate—Pruritus—Ifosfamide—testicular cancer	0.000563	0.0018	CcSEcCtD
Pentosan Polysulfate—Haematuria—Methotrexate—testicular cancer	0.000563	0.0018	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Epirubicin—testicular cancer	0.000561	0.00179	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Etoposide—testicular cancer	0.000561	0.00179	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—testicular cancer	0.000559	0.00179	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Methotrexate—testicular cancer	0.000557	0.00178	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by NGF—KIT—testicular cancer	0.000556	0.000972	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Bleomycin—testicular cancer	0.000554	0.00177	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—FGFR3—testicular cancer	0.000553	0.000966	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Dactinomycin—testicular cancer	0.000553	0.00177	CcSEcCtD
Pentosan Polysulfate—Rash—Dactinomycin—testicular cancer	0.000548	0.00175	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Etoposide—testicular cancer	0.000547	0.00175	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Ifosfamide—testicular cancer	0.000545	0.00174	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—FGFR3—testicular cancer	0.000545	0.000952	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—INSL3—testicular cancer	0.000542	0.000948	CbGpPWpGaD
Pentosan Polysulfate—Jaundice—Epirubicin—testicular cancer	0.000539	0.00172	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Epirubicin—testicular cancer	0.000539	0.00172	CcSEcCtD
Pentosan Polysulfate—Constipation—Etoposide—testicular cancer	0.000538	0.00172	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Epirubicin—testicular cancer	0.000537	0.00172	CcSEcCtD
Pentosan Polysulfate—Sweating—Epirubicin—testicular cancer	0.00053	0.0017	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—testicular cancer	0.00053	0.0017	CcSEcCtD
Pentosan Polysulfate—Haematuria—Epirubicin—testicular cancer	0.000527	0.00169	CcSEcCtD
Pentosan Polysulfate—Dizziness—Ifosfamide—testicular cancer	0.000527	0.00168	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Methotrexate—testicular cancer	0.000526	0.00168	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000524	0.00168	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—FGFR3—testicular cancer	0.000523	0.000914	CbGpPWpGaD
Pentosan Polysulfate—Weight increased—Doxorubicin—testicular cancer	0.000522	0.00167	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Epirubicin—testicular cancer	0.000521	0.00167	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Doxorubicin—testicular cancer	0.000519	0.00166	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Epirubicin—testicular cancer	0.000519	0.00166	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Etoposide—testicular cancer	0.000518	0.00166	CcSEcCtD
Pentosan Polysulfate—Nausea—Dactinomycin—testicular cancer	0.000516	0.00165	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Etoposide—testicular cancer	0.000514	0.00165	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—KIT—testicular cancer	0.000507	0.000887	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Ifosfamide—testicular cancer	0.000506	0.00162	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Cisplatin—testicular cancer	0.000506	0.00162	CcSEcCtD
Pentosan Polysulfate—Rash—Ifosfamide—testicular cancer	0.000502	0.00161	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Ifosfamide—testicular cancer	0.000502	0.0016	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—KIT—testicular cancer	0.0005	0.000874	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Etoposide—testicular cancer	0.0005	0.0016	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—testicular cancer	0.000499	0.00159	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—testicular cancer	0.000499	0.00159	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Epirubicin—testicular cancer	0.000498	0.00159	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Etoposide—testicular cancer	0.000497	0.00159	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—testicular cancer	0.000497	0.00159	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Methotrexate—testicular cancer	0.000494	0.00158	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Epirubicin—testicular cancer	0.000493	0.00158	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—testicular cancer	0.00049	0.00157	CcSEcCtD
Pentosan Polysulfate—Haematuria—Doxorubicin—testicular cancer	0.000488	0.00156	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—testicular cancer	0.000482	0.00154	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—KIT—testicular cancer	0.00048	0.000839	CbGpPWpGaD
Pentosan Polysulfate—Sinusitis—Doxorubicin—testicular cancer	0.00048	0.00154	CcSEcCtD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—MMP2—testicular cancer	0.000479	0.000838	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Ifosfamide—testicular cancer	0.000473	0.00151	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Cisplatin—testicular cancer	0.00047	0.0015	CcSEcCtD
Pentosan Polysulfate—Alopecia—Methotrexate—testicular cancer	0.000469	0.0015	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—KITLG—testicular cancer	0.000465	0.000813	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Etoposide—testicular cancer	0.000463	0.00148	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Epirubicin—testicular cancer	0.000463	0.00148	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—testicular cancer	0.00046	0.00147	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—testicular cancer	0.000456	0.00146	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—BCL10—testicular cancer	0.000449	0.000785	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KITLG—testicular cancer	0.000447	0.00078	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Etoposide—testicular cancer	0.000445	0.00142	CcSEcCtD
Pentosan Polysulfate—Alopecia—Epirubicin—testicular cancer	0.000439	0.0014	CcSEcCtD
Pentosan Polysulfate—Vomiting—Cisplatin—testicular cancer	0.000437	0.0014	CcSEcCtD
Pentosan Polysulfate—Rash—Cisplatin—testicular cancer	0.000433	0.00138	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Cisplatin—testicular cancer	0.000432	0.00138	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Etoposide—testicular cancer	0.00043	0.00138	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Methotrexate—testicular cancer	0.000428	0.00137	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—H2AFZ—testicular cancer	0.000428	0.000748	CbGpPWpGaD
Pentosan Polysulfate—Tinnitus—Doxorubicin—testicular cancer	0.000428	0.00137	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—KITLG—testicular cancer	0.000427	0.000746	CbGpPWpGaD
Pentosan Polysulfate—Anaemia—Methotrexate—testicular cancer	0.000427	0.00136	CcSEcCtD
Pentosan Polysulfate—Flatulence—Epirubicin—testicular cancer	0.000426	0.00136	CcSEcCtD
Pentosan Polysulfate—FGF2—Innate Immune System—KITLG—testicular cancer	0.000424	0.000741	CbGpPWpGaD
Pentosan Polysulfate—Malaise—Methotrexate—testicular cancer	0.000416	0.00133	CcSEcCtD
Pentosan Polysulfate—Dizziness—Etoposide—testicular cancer	0.000416	0.00133	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Methotrexate—testicular cancer	0.000413	0.00132	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—BCL10—testicular cancer	0.00041	0.000716	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Cisplatin—testicular cancer	0.000408	0.0013	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KITLG—testicular cancer	0.000407	0.000712	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Doxorubicin—testicular cancer	0.000406	0.0013	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Epirubicin—testicular cancer	0.000401	0.00128	CcSEcCtD
Pentosan Polysulfate—Vomiting—Etoposide—testicular cancer	0.0004	0.00128	CcSEcCtD
Pentosan Polysulfate—Anaemia—Epirubicin—testicular cancer	0.000399	0.00128	CcSEcCtD
Pentosan Polysulfate—Agitation—Epirubicin—testicular cancer	0.000397	0.00127	CcSEcCtD
Pentosan Polysulfate—Rash—Etoposide—testicular cancer	0.000397	0.00127	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Etoposide—testicular cancer	0.000396	0.00127	CcSEcCtD
Pentosan Polysulfate—Headache—Etoposide—testicular cancer	0.000394	0.00126	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—KITLG—testicular cancer	0.000394	0.000689	CbGpPWpGaD
Pentosan Polysulfate—Flatulence—Doxorubicin—testicular cancer	0.000394	0.00126	CcSEcCtD
Pentosan Polysulfate—Myalgia—Methotrexate—testicular cancer	0.000393	0.00126	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Methotrexate—testicular cancer	0.000393	0.00126	CcSEcCtD
Pentosan Polysulfate—Malaise—Epirubicin—testicular cancer	0.00039	0.00125	CcSEcCtD
Pentosan Polysulfate—Discomfort—Methotrexate—testicular cancer	0.000388	0.00124	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Epirubicin—testicular cancer	0.000387	0.00124	CcSEcCtD
Pentosan Polysulfate—Infection—Methotrexate—testicular cancer	0.000374	0.0012	CcSEcCtD
Pentosan Polysulfate—Nausea—Etoposide—testicular cancer	0.000374	0.0012	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—testicular cancer	0.000371	0.00119	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—testicular cancer	0.000369	0.00118	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Methotrexate—testicular cancer	0.000369	0.00118	CcSEcCtD
Pentosan Polysulfate—Myalgia—Epirubicin—testicular cancer	0.000368	0.00118	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Epirubicin—testicular cancer	0.000368	0.00118	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—testicular cancer	0.000367	0.00118	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Methotrexate—testicular cancer	0.000364	0.00117	CcSEcCtD
Pentosan Polysulfate—Discomfort—Epirubicin—testicular cancer	0.000363	0.00116	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—testicular cancer	0.00036	0.00115	CcSEcCtD
Pentosan Polysulfate—Anorexia—Methotrexate—testicular cancer	0.000359	0.00115	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Doxorubicin—testicular cancer	0.000358	0.00114	CcSEcCtD
Pentosan Polysulfate—Oedema—Epirubicin—testicular cancer	0.000353	0.00113	CcSEcCtD
Pentosan Polysulfate—Infection—Epirubicin—testicular cancer	0.00035	0.00112	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—FGFR3—testicular cancer	0.000346	0.000604	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Epirubicin—testicular cancer	0.000345	0.0011	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000343	0.0011	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Epirubicin—testicular cancer	0.000341	0.00109	CcSEcCtD
Pentosan Polysulfate—Insomnia—Methotrexate—testicular cancer	0.000341	0.00109	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—testicular cancer	0.00034	0.00109	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—testicular cancer	0.00034	0.00109	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Methotrexate—testicular cancer	0.000338	0.00108	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—testicular cancer	0.000336	0.00108	CcSEcCtD
Pentosan Polysulfate—Anorexia—Epirubicin—testicular cancer	0.000336	0.00108	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Methotrexate—testicular cancer	0.000336	0.00107	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—FGFR3—testicular cancer	0.000332	0.00058	CbGpPWpGaD
Pentosan Polysulfate—Dyspepsia—Methotrexate—testicular cancer	0.000332	0.00106	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Methotrexate—testicular cancer	0.000328	0.00105	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—testicular cancer	0.000326	0.00104	CcSEcCtD
Pentosan Polysulfate—Infection—Doxorubicin—testicular cancer	0.000324	0.00104	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000321	0.00103	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—testicular cancer	0.000319	0.00102	CcSEcCtD
Pentosan Polysulfate—Insomnia—Epirubicin—testicular cancer	0.000319	0.00102	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—KIT—testicular cancer	0.000317	0.000555	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—FGFR3—testicular cancer	0.000317	0.000554	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Epirubicin—testicular cancer	0.000317	0.00101	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—testicular cancer	0.000315	0.00101	CcSEcCtD
Pentosan Polysulfate—FGF2—Innate Immune System—FGFR3—testicular cancer	0.000315	0.000551	CbGpPWpGaD
Pentosan Polysulfate—Dyspnoea—Epirubicin—testicular cancer	0.000314	0.00101	CcSEcCtD
Pentosan Polysulfate—Anorexia—Doxorubicin—testicular cancer	0.000311	0.000995	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Methotrexate—testicular cancer	0.00031	0.000993	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Epirubicin—testicular cancer	0.00031	0.000993	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Methotrexate—testicular cancer	0.000308	0.000985	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Epirubicin—testicular cancer	0.000306	0.00098	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KIT—testicular cancer	0.000305	0.000533	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—FGFR3—testicular cancer	0.000303	0.000529	CbGpPWpGaD
Pentosan Polysulfate—Constipation—Epirubicin—testicular cancer	0.000302	0.000964	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—H2AFZ—testicular cancer	0.0003	0.000524	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Methotrexate—testicular cancer	0.000299	0.000957	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—STK11—testicular cancer	0.000298	0.000521	CbGpPWpGaD
Pentosan Polysulfate—Abdominal pain—Methotrexate—testicular cancer	0.000298	0.000953	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000297	0.000951	CcSEcCtD
Pentosan Polysulfate—Insomnia—Doxorubicin—testicular cancer	0.000295	0.000944	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—testicular cancer	0.000293	0.000937	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—FGFR3—testicular cancer	0.000293	0.000512	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KIT—testicular cancer	0.000291	0.000509	CbGpPWpGaD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—testicular cancer	0.000291	0.00093	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Epirubicin—testicular cancer	0.000291	0.000929	CcSEcCtD
Pentosan Polysulfate—FGF2—Developmental Biology—MMP2—testicular cancer	0.00029	0.000507	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KIT—testicular cancer	0.000289	0.000506	CbGpPWpGaD
Pentosan Polysulfate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000288	0.000922	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—testicular cancer	0.000287	0.000919	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—testicular cancer	0.000284	0.000907	CcSEcCtD
Pentosan Polysulfate—Urticaria—Epirubicin—testicular cancer	0.00028	0.000896	CcSEcCtD
Pentosan Polysulfate—Constipation—Doxorubicin—testicular cancer	0.000279	0.000892	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Epirubicin—testicular cancer	0.000279	0.000892	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KIT—testicular cancer	0.000278	0.000486	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Methotrexate—testicular cancer	0.000278	0.000888	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—KITLG—testicular cancer	0.000276	0.000482	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—H2AFZ—testicular cancer	0.000272	0.000475	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KITLG—testicular cancer	0.000271	0.000473	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KIT—testicular cancer	0.000269	0.00047	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—testicular cancer	0.000269	0.00086	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000267	0.000853	CcSEcCtD
Pentosan Polysulfate—Pruritus—Methotrexate—testicular cancer	0.000267	0.000853	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Epirubicin—testicular cancer	0.00026	0.000831	CcSEcCtD
Pentosan Polysulfate—Urticaria—Doxorubicin—testicular cancer	0.000259	0.000829	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—testicular cancer	0.000258	0.000825	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Methotrexate—testicular cancer	0.000258	0.000825	CcSEcCtD
Pentosan Polysulfate—FGF1—Disease—KITLG—testicular cancer	0.00025	0.000437	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Epirubicin—testicular cancer	0.000249	0.000798	CcSEcCtD
Pentosan Polysulfate—Dizziness—Methotrexate—testicular cancer	0.000249	0.000797	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—H2AFZ—testicular cancer	0.000248	0.000433	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KITLG—testicular cancer	0.000247	0.000432	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Epirubicin—testicular cancer	0.000241	0.000772	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—testicular cancer	0.00024	0.000769	CcSEcCtD
Pentosan Polysulfate—Vomiting—Methotrexate—testicular cancer	0.00024	0.000766	CcSEcCtD
Pentosan Polysulfate—Rash—Methotrexate—testicular cancer	0.000238	0.00076	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Methotrexate—testicular cancer	0.000237	0.000759	CcSEcCtD
Pentosan Polysulfate—Headache—Methotrexate—testicular cancer	0.000236	0.000755	CcSEcCtD
Pentosan Polysulfate—Dizziness—Epirubicin—testicular cancer	0.000233	0.000746	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—testicular cancer	0.000231	0.000738	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—KITLG—testicular cancer	0.000228	0.000399	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Epirubicin—testicular cancer	0.000224	0.000717	CcSEcCtD
Pentosan Polysulfate—Nausea—Methotrexate—testicular cancer	0.000224	0.000716	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—testicular cancer	0.000223	0.000714	CcSEcCtD
Pentosan Polysulfate—Rash—Epirubicin—testicular cancer	0.000222	0.000711	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Epirubicin—testicular cancer	0.000222	0.00071	CcSEcCtD
Pentosan Polysulfate—Headache—Epirubicin—testicular cancer	0.000221	0.000707	CcSEcCtD
Pentosan Polysulfate—Dizziness—Doxorubicin—testicular cancer	0.000216	0.00069	CcSEcCtD
Pentosan Polysulfate—Nausea—Epirubicin—testicular cancer	0.000209	0.00067	CcSEcCtD
Pentosan Polysulfate—Vomiting—Doxorubicin—testicular cancer	0.000207	0.000663	CcSEcCtD
Pentosan Polysulfate—Rash—Doxorubicin—testicular cancer	0.000206	0.000658	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—testicular cancer	0.000206	0.000657	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—FGFR3—testicular cancer	0.000205	0.000358	CbGpPWpGaD
Pentosan Polysulfate—Headache—Doxorubicin—testicular cancer	0.000204	0.000654	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—FGFR3—testicular cancer	0.000201	0.000352	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Doxorubicin—testicular cancer	0.000194	0.00062	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling Pathways—H2AFZ—testicular cancer	0.00019	0.000333	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STK11—testicular cancer	0.000189	0.000331	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KIT—testicular cancer	0.000188	0.000329	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FGFR3—testicular cancer	0.000186	0.000325	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KIT—testicular cancer	0.000185	0.000323	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—FGFR3—testicular cancer	0.000184	0.000321	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KITLG—testicular cancer	0.000175	0.000306	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—H2AFZ—testicular cancer	0.000174	0.000303	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STK11—testicular cancer	0.000173	0.000302	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KIT—testicular cancer	0.000171	0.000298	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—FGFR3—testicular cancer	0.000169	0.000296	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KIT—testicular cancer	0.000169	0.000295	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KITLG—testicular cancer	0.00016	0.000279	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KIT—testicular cancer	0.000156	0.000272	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGFR3—testicular cancer	0.00013	0.000227	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KIT—testicular cancer	0.000119	0.000209	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FGFR3—testicular cancer	0.000119	0.000207	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KIT—testicular cancer	0.000109	0.00019	CbGpPWpGaD
